Published Date: Oct 2024 | Report ID: MI1113 | 215 Pages
The Europe Diabetes Care Devices market accounted for USD 9.2 Billion in 2024 and is expected to reach USD 24.4 Billion by 2035, growing at a CAGR of around 9.3% between 2025 and 2035. The Diabetes Care Devices Market in Europe involves multiple products for assisting the self-management of diabetes. The scope of this market includes devices such as blood glucose monitors, insulin delivery systems (pumps and pens), continuous glucose monitoring systems, and digital health solutions. Due to the rise in the incidence of diabetes in Europe owing to lifestyle changes and population aging, there is a demand for new and user-friendly devices. Recent advancement in technologies, including smart devices and compatible equipment, creates an enhancement in patient care and self-management. The market consists of well-established participants and new dynamic players.
| Parameter | Details |
|---|---|
| Largest Market | Germany |
| Fastest Growing Market | France |
| Base Year | 2024 |
| Market Size in 2024 | USD 9.2 Billion |
| CAGR (2025-2035) | 9.3% |
| Forecast Years | 2025-2035 |
| Historical Data | 2018-2024 |
| Market Size in 2035 | USD 24.4 Billion |
| Countries Covered | Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Belgium, Sweden, Poland, Portugal, Greece, Czech Republic, Hungary, Finland, and Others |
| What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and over 10 companies |
| Segments Covered | Product Type, Technology, Distribution Channel, End-User, and Country |
To explore in-depth analysis in this report - Request Free Sample Report
Increased customer awareness of diabetes treatments, the development of innovative diabetes devices like glucose monitors, and the prevalence of diabetes are driving the need for personalized equipment in Europe diabetes care devices market. Technological advancements like CGM and smart insulin pens have seen enhanced patient compliance with the treatment plan. The desire for these devices is fueled by the improvement of understanding of the disease and its management. The European Centre for Disease Prevention and Control (ECDC) report of 2020 showed that 32 million adults in the EU have been diagnosed with diabetes. That underscores the need for better diabetes care technologies in the management of this health issue.
Improved insurance coverage for the purchase of better diabetic care equipment, such as insulin pumps and CGMs, improves the Europe diabetes care devices market. Along with improving adherence to medical advice to improve patients' health, it also relieves them of the financial strain associated with covering their medical expenses. Furthermore, the prevalence of diabetes is rising in Europe, and awareness of proactive diabetes management is driving the market's growth.
The International Diabetes Federation (IDF) selected Europe as the region with the second-highest diabetes population in 2021 and clarified why 60 million European individuals are dependent on innovative forms of care. This shows a rising need for quality diabetes care devices and the regional healthcare policies.
The Europe Diabetes Care Devices Market faces some challenges, like low awareness in the rural regions. This keeps many people in these regions in the dark about the new technologies in the management of diabetes, leading to low uptake. Further, a drawback of expensive devices of a higher caliber is to restrict the patient from purchasing necessary supplies to help with their care. Lack of adequate training for healthcare workers and poor healthcare facilities increased the chances of patients not using those devices correctly. Entry into new markets for technologies is hampered by political factors and the diverse or complicated legal and healthcare system systems. These factors make Europe’s rural regions experience a low growth rate in the consumption of diabetes care devices.
The Europe Diabetes Care Devices Market offers significant opportunities automated with the increasing need for environment-friendly sources. Customers' increasing awareness of environmental conservation is indicative that products should be developed using biodegradable materials and production processes and can assist manufacturers. This targets health-conscious consumers because it has less impact on the environment than current welfare ideas in Europe. Adopting sustainable tactics will enhance the company's competitive edge and raise customer loyalty and market share. In general, the use of measures with minimal impact on the environment and resources is the key to a company's development and customer satisfaction.
One of the key factors of the European Diabetes Care Devices market expansion is the demand for device connectivity through apps. Since the number of patients diagnosed with diabetes is continuously rising, there is an enhanced need to find better ways to engage patients while managing the disease. Novel gadgets, including CGM and insulins, with the help of applications make it convenient for patients to monitor themselves and interact with their devices in real-time. Among these integrated systems are pager remote monitor screens, enabling prompt interference or treatment and improving patient outcomes. This trend is being driven by the growing acceptance of telehealth and digital health in Europe. It offers more possibilities for connected diabetes care solutions. It is important to develop because it improves patient compliance and reduces the expenses that healthcare facilities will bear.
“GlucoRx BioXensor has standout accuracy owing to its multi sensor approach capturing blood glucose as well as Sp02, ECG, respiration rate, heart rate, temperature, activity, sleep, and early fall detection. The wearable device has a longer shelf-life because it is not chemical in its action.”
“The wearable arm gadget sends information to a mobile app and allows people with type 1 diabetes to keep track of their glucose levels without having to scan or take a finger prick test.”
Based on the product type, the Europe Diabetes Care Devices market is classified into Blood Glucose Monitoring Devices and Treatment Devices. Blood Glucose Monitoring Devices is the largest division in this market. This prominence originates from the mounting rates of diabetes mellitus and the shifting focus on patient auto-administration. Technological enhancements, including brand-new CGM systems, have transformed the examination of blood glucose and enhanced the value of patients. The increased diabetes awareness and the need for accurate and user-friendly monitoring devices support this segment’s popularity. The focus on individualized treatment and advancement of technologies puts Blood Glucose Monitoring Devices as the market leaders.
Would you like to review the price list for each section?
Based on the technology, the Europe Pacific Diabetes Care Devices market is classified into Wearable Devices and Non-Wearable Devices. Wearable Devices are dominant in Europe Diabetes Care Devices Market. Technological advances supporting continuous glucose monitoring empowered the segment to supply real-time data and insights, engaging users with smarter solutions for diabetes management. Wearables like smartwatches and continuous glucose monitors (CGMs) get patients involved in their care, enhance their engagement, and promote effective management of diabetes. The utilization of devices pampered the growing demand for personalized health solutions. Mobile apps enable patients to keep a healthy track of their metrics, fortifying the position of wearables as the leading force in diabetes care.
The geographic conditions of the Diabetes Care Devices Market in Germany indicate the developed healthcare system and the increasing attention to diabetes problems. Germany is one of the worst-affected diabetic countries in Europe and has experienced a rise in newly researched and developed products like CGM and insulin pumps.
The market is focused on innovation and is backed up by leading medical technology companies and research partnerships. Furthermore, ongoing and planned measures of the German government to advance digital health technologies and improve the availability of diabetes treatment create further market growth. The shift towards individualized care and the use of telemedicine is defining the market and guaranteeing the effective delivery of unique narratives for patient care. The analysis confirms that Germany keeps its strategic role in the European market of diabetes care devices.
The Diabetes Care Devices Market is expanding in France due to the increasing cases of diabetes and enhanced health consciousness. France has recorded a high uptake of new technologies such as CGMs and insulin pumps through a strong healthcare framework and reimbursement. Finally, this partnership has driven the creation of easy-to-use devices by tech firms in concert with healthcare facilities. This is in line with the trend toward the use of digital health solutions, m-Health, where patients use their mobile application to track glucose levels and promote patient management. Owing to population aging and a prevalence of lifestyle-related diabetes, there is growth potential in France, and the company is consolidating its strategic place in the European diabetes sector.
The UK is a growing country in Europe Diabetes Care Devices Market due to the increasing prevalence of diabetes and a focus on the latest technology in healthcare. Advancements in continuous glucose monitoring systems and insulin delivery devices have received much acceptance among patients and medical practitioners. The market’s growth is supported by the well-developed healthcare system in the UK and the governmental drives for effective diabetes treatment.
Strategic partnerships between healthcare facilities and technology companies encourage the industry to generate easy-to-use products to improve patient compliance. With the growth in awareness of diabetes care, the market is set to grow further, making the UK a prominent contender in Europe’s diabetes care device market.
The competitive analysis of the Europe Diabetes Care Devices Market reveals the presence of the market’s traditional players and newcomers, who introduced new technologies. Market leaders such as Ypsomed and GlucoMen aim to improve the ease of using new glucose monitoring technologies and smart insulin delivery systems. Ypsomed is launching the MyLife YpsoPump, which can link with digital health platforms for better diabetes management. Dario has advanced with its mobile health DarioHealth app for diabetes care solutions. Moreover, firms such as Boehringer Ingelheim are considering partners as they seek to harness digital health solutions and seek better patient outcomes. These clients further ramp up product innovation and expansion since the demand for efficient diabetes management solutions stays prominent in this sector.
Europe Diabetes Care Devices Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Free Sample Report
By Product Type
By Technology
By Distribution Channel
By End-User
By Region
Europe
List of Companies:
The Europe Diabetes Care Devices market accounted for USD 9.2 Billion in 2024 and is expected to reach USD 24.4 Billion by 2035, growing at a CAGR of around 9.3% between 2025 and 2035.
Key growth opportunities in the Europe Diabetes Care Devices market include leveraging digital transformation, such as emphasis on prevention promotes early detection and management devices, eco-friendly options attract environmentally conscious consumers in market, and combining devices with apps enhances patient engagement and monitoring.
Product type is currently leading in the Europe Diabetes Care Devices Market due to Blood glucose monitoring devices. This dominates the Market due to their essential role in diabetes management, enabling patients to track their glucose levels effectively. The increasing prevalence of diabetes, coupled with advancements in technology such as continuous glucose monitors (CGMs) and smart meters, has driven demand for these devices, fostering better health outcomes and improved patient adherence.
Germany is expected to remain the dominant country due to its robust healthcare infrastructure, high investment in medical technology, and a strong emphasis on research and innovation. The country’s well-established healthcare policies, coupled with a large population of diabetes patients, create significant demand for advanced diabetes care solutions, positioning Germany as a key player in this sector.
France is the fastest-growing country due to increasing awareness of diabetes management and a rising prevalence of the disease. Government initiatives to promote innovative healthcare solutions and investments in digital health technologies are driving rapid adoption of advanced diabetes devices, making France a dynamic market for growth in this sector.
Key operating players in the Europe Diabetes Care Devices market are Ypsomed, GlucoMen, Owen Mumford, Boehringer Ingelheim, Novartis, Lifescan, F. Hoffmann-La Roche AG, and Diasend. These companies leverage advanced technology to develop user-friendly and effective diabetes management solutions, coupled with robust distribution networks and strategic partnerships that enhance their market presence and customer reach.
Explore the comprehensive analysis of the North American Diabetes Care Devices. Discover insights on trends, Product Type, Technology, Distribution Channel, End-User, Country, & leading company profiles.
Explore the comprehensive analysis of the Asia Pacific Diabetes Care Devices Market. Discover insights on trends, Product Type, Technology, Distribution Channel, End-User, Country, & leading company profiles.
Explore the comprehensive analysis of global Diabetes Care Devices. Discover insights on trends, Product Type, Technology, Distribution Channel, End-User, Region, & leading company profiles.
Our analysts are ready to help you immediately.
We have received your request for Europe Diabetes Care Devices Market research report. We value your interest in our services and are pleased to inform you that our dedicated research specialist will be reaching out to you shortly. If you have any further questions or require additional assistance, feel free to let us know via-